CRP and breast carcinoma: Neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), c-reactive protein (CRP), and systemic immune-inflammation index (SII) are some disease markers or models that have been shown to be able to predict the prognosis of breast cancer [[3], [4], [5]].